481 In vitro and vivo evaluation of the pan FGFR inhibitor ARQ 087 and selective pan AKT inhibitor ARQ 092 in endometrial cancer: potential for combination therapy

Meade, Justin; Wick, Michael J.; Vaught, Teresa L.; Chavez, Roger; Rundle, Melissa M.; Stanfield, Kristina M.; Quattrochi, Brian; Papadopoulos, K.; Dransfield, Daniel T.; Yu, Yunfang

doi:10.1016/s0959-8049(14)70607-0

481 In vitro and vivo evaluation of the pan FGFR inhibitor ARQ 087 and selective pan AKT inhibitor ARQ 092 in endometrial cancer: potential for combination therapy

NobleIDNI4P00W78R68S16

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/033CD3A4.svg?ark=w1%2F20260521%2F033CD3A4&value=id)](https://nobleid.org/work/w1/20260521/033CD3A4)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kristina M. Stanfield

Claim authorship of this work

481 In vitro and vivo evaluation of the pan FGFR inhibitor ARQ 087 and selective pan AKT inhibitor ARQ 092 in endometrial cancer: potential for combination therapy

NobleIDNI4P00W78R68S16

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/033CD3A4.svg?ark=w1%2F20260521%2F033CD3A4&value=id)](https://nobleid.org/work/w1/20260521/033CD3A4)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kristina M. Stanfield

Claim authorship of this work